And then there were 15. Two Bay Area biotech companies — one that started its first clinical trial in eye diseases in July, the other a pioneer in the fledgling field of hunting down cancer via a simple blood draw — seek to raise $100 million each in the region’s 14th and 15th life sciences initial public offerings this year. It is the most life sciences IPOs in the Bay Area in a calendar year since 19 were filed in 2014. Guardant Health Inc. of Redwood City and Kodiak Sciences Inc. of Palo…
Read more from the original source:
Two more Peninsula IPOs tell the story of biotech’s investment boom
